In addition, in experiments on the triple transgenic mouse 3xTg-AD (a mouse line that expresses APP, presenilin 2, and human tau), it was found that pioglitazone treatment improved learning in a hippocampal-dependent task [24] and this was evaluated with the MWM test [25]. This evidence concerns the gene MAPT and Alzheimer disease.